Ultrasonographic evaluation of vascular remodeling and patency after drug-coated balloon treatment for arteriovenous fistula stenosis
The Journal of Vascular Access · 2026
DOI: 10.1177/11297298251397293 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Vascular Access, 2026. Verfasst von Hiroaki Haruguchi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Haruguchi Vascular Access Clinic, Tokyo, Japan. Hauptthemen laut MEDLINE: Arteriovenous Fistula, Vascular Remodeling, Angioplasty, Balloon, Vascular Patency. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Background
Drug-coated balloons (DCBs) have shown promise in prolonging arteriovenous fistula (AVF) patency by inhibiting neointimal hyperplasia. However, few studies have longitudinally evaluated vascular remodeling after DCB treatment using ultrasound. This study aimed to evaluate vascular remodeling after DCB treatment using high-frequency ultrasound.
Methods
In this retrospective single-center study, 50 patients with single AVF stenosis were treated with DCB and followed by ultrasound at four time points: pre-treatment, immediately post-treatment, 3 months, and 6 months. Patients were classified into short-term ( n = 24; reintervention within 6–9 months) and long-term ( n = 26; patency ⩾18 months) groups. The mean follow-up time in the long-term group was 24.5 months. Nineteen patients had complete ultrasound data every 3 months up to 15 months. Parameters included lumen cross-sectional area (L-CSA), external cross-sectional area (E-CSA), and intima-media thickness area (IMT area).
Results
Baseline demographics were similar between groups. L-CSA was significantly larger in the long-term group both immediately post-DCB (14.4 ± 5.9 vs 9.9 ± 3.9 mm², p < 0.001) and at 6 months (5.3 ± 2.2 vs 3.1 ± 1.3 mm², p < 0.001). E-CSA was also greater in the long-term group at 6 months (21.7 ± 8.8 vs 14.7 ± 5.0 mm², p < 0.001). While there was no significant difference in IMT area immediately post-treatment, it was significantly greater in the long-term group at 6 months (16.3 ± 7.8 vs 11.6 ± 7.8 mm², p < 0.001). No significant changes in L-CSA, E-CSA, or IMT were observed beyond 6 months.
Conclusions
Regular ultrasound examinations enable accurate evaluation of vascular remodeling. Initial vessel dilation and sustained external diameter enlargement may contribute to long-term morphological stability and patency following DCB treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Haruguchi Vascular Access Clinic, Tokyo, Japan.
- Department of Vascular Surgery, IMS Fujimi General Hospital, Saitama Prefecture, Japan.
ORCID-Profile: Hiroaki Haruguchi, Kazuki Haruguhi
Zitieren
APA
Haruguchi, H., & Haruguhi, K. (2026). Ultrasonographic evaluation of vascular remodeling and patency after drug-coated balloon treatment for arteriovenous fistula stenosis. The Journal of Vascular Access. https://doi.org/10.1177/11297298251397293
Vancouver
Haruguchi H, Haruguhi K. Ultrasonographic evaluation of vascular remodeling and patency after drug-coated balloon treatment for arteriovenous fistula stenosis. The Journal of Vascular Access. 2026. doi:10.1177/11297298251397293
BibTeX
@article{Haruguchi2026,
author = {Haruguchi, Hiroaki and Haruguhi, Kazuki},
title = {Ultrasonographic evaluation of vascular remodeling and patency after drug-coated balloon treatment for arteriovenous fistula stenosis},
journal = {The Journal of Vascular Access},
year = {2026},
doi = {10.1177/11297298251397293}
}
EUVIMED